Blue Trust Inc’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Blue Trust Inc’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-126	Closed	-$5.15K	–	3082
2024 Q3	$5.15K	Buy	126 +7	+6%	+$297	﹤0.01%	2393
2024 Q2	$5.03K	Buy	119 +23	+24%	+$958	﹤0.01%	2202
2024 Q1	$4.06K	Sell	96 -37	-28%	-$1.55K	﹤0.01%	1676
2023 Q4	$3K	Buy	+133	New	+$3.82K	﹤0.01%	2073
2023 Q2	–	Sell	-7	Closed	–	–	2626
2023 Q1	$0	Buy	+7	New	+$205	﹤0.01%	2702

Blue Trust Inc's CERE Position: Q4 2024 in Review

Blue Trust Inc sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q4 2024, closing a stake of 126 shares — an estimated $5.15K sold.

Blue Trust Inc first reported a position in CERE in Q1 2023 and held it in 5 quarters. The position peaked at $5.15K in Q3 2024. 0 funds tracked by Wall St. Rank hold CERE as of Q4 2024.

Blue Trust Inc reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Blue Trust Inc sold 126 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q4 2024, an estimated $5.15K.
Blue Trust Inc first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
Blue Trust Inc's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $5.15K in Q3 2024.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.